SOAT1 and inflammatory bowel disease: Research on IBD therapy has advanced on the past few years, and inflammatory cytokines or specific cellular pathways such as JAK/STAT and phosphodiesterase-4 have all been explored as potential targets for IBD treatment (Pekow, 2017).